J M Monaghan Selected Research

Residual Neoplasm

8/2000

Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J M Monaghan Research Topics

Disease

7	Neoplasms (Cancer) 03/2006 - 08/2000
3	Ovarian Epithelial Carcinoma 01/2006 - 01/2000
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2004 - 01/2001
2	Neoplasm Metastasis (Metastasis) 12/2004 - 08/2000
1	Uterine Cervical Dysplasia 06/2005
1	Pulmonary Embolism 12/2004
1	Uterine Inversion (Inversion of Uterus) 11/2003
1	Carcinoma (Carcinomatosis) 08/2003
1	Vaginal Neoplasms (Cancer, Vaginal) 06/2001
1	Melanoma (Melanoma, Malignant) 01/2001
1	Urinary Incontinence 01/2001
1	Residual Neoplasm 08/2000
1	Endometrial Neoplasms (Endometrial Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

2	Indicators and Reagents (Reagents)IBA 08/2000 - 01/2000
1	indole-3-carbinolIBA 03/2006
1	GonadotropinsIBA 01/2006
1	Tamoxifen FDA LinkGeneric 11/2003
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 11/2003
1	Biological ProductsIBA 01/2001

Therapy/Procedure

3	Hysterectomy 06/2005 - 01/2001
2	Vaginal Hysterectomy 12/2004 - 01/2000
1	Cystotomy 12/2004
1	Laparotomy 08/2003
1	Radiotherapy 06/2001
1	Conservative Treatment 01/2001
1	Operative Surgical Procedures 08/2000
1	Lymph Node Excision (Lymph Node Dissection) 08/2000
1	Cytoreduction Surgical Procedures 08/2000